SEC Whistleblower Program – Reporting Securities Fraud and Financial Rewards

SEC Whistleblower Program Explained: How It Works & Benefits //

The SEC Whistleblower Program (“SEC Whistleblower Program”) was established by Congress to incentivize whistleblowers to report specific, timely and credible information about possible federal securities laws violations.

Whistleblowers who provide original, high-quality information that leads to a successful enforcement action may be eligible for financial rewards ranging from 10% to 30% of the money collected when the monetary sanctions exceed $1 million.

In May 2023, the U.S. Securities and Exchange Commission (“SEC”) announced the largest-ever award, nearly $279 million, to a whistleblower whose information and assistance led to the successful enforcement of SEC and related actions. This is the highest award in the SEC’s whistleblower program’s history, more than doubling the $114 million whistleblower award the SEC issued in October 2020.

In FY 2024, the SEC awarded over $255 million to 47 whistleblowers, marking the third-highest annual total in the program’s history.

According to the SEC Office of the Whistleblower Annual Report to Congress for FY 2024, more than $2.2 billion has been awarded by the SEC to 444 individual whistleblowers since the SEC Whistleblower Program’s inception in 2011.

Whistleblower Confidentiality

Confidentiality is a cornerstone of the SEC Whistleblower Program. Under the Dodd-Frank Act, the SEC is prohibited from disclosing any information that could reasonably be expected to reveal a whistleblower’s identity, except under limited circumstances.

To protect whistleblowers, the SEC redacts identifying details from public award orders, including names, enforcement action details, and award percentages.

Who Can Be a Whistleblower?

Anyone with credible, original information about violations of federal securities laws can be a whistleblower. This includes employees, investors, industry insiders, and others who witness misconduct.

The SEC allows anonymous reporting if the whistleblower is represented by an attorney.

Even individuals involved in the misconduct may be eligible for an award, though their participation could impact the reward amount.

Whistleblowers can be either insiders (such as current or former employees of the violating entity) or outsiders (such as investors, competitors, or market analysts). In FY 2024, 38% of whistleblowers who received awards were outsiders, while 62% were insiders.

What Information Can I Submit to the SEC?

The SEC investigates possible violations of federal securities laws. The more specific, credible, and timely a whistleblower tip, the more likely it is that the tip will be forwarded to investigative staff.

High-quality tips include:

  • Identifying individuals involved in the scheme
  • Providing examples of fraudulent transactions
  • Submitting non-public materials evidencing fraud

The SEC does not have jurisdiction over matters outside federal securities laws but may refer cases to other regulatory agencies when appropriate.

Examples of misconduct the SEC investigates include:

  • Ponzi schemes, pyramid schemes, or high-yield investment programs
  • Theft or misappropriation of funds or securities
  • Manipulation of a security’s price or volume
  • Insider trading
  • Fraudulent or unregistered securities offerings
  • False or misleading statements about a company (including SEC reports or financial statements)
  • Abusive naked short selling
  • Bribery of, or improper payments to, foreign officials
  • Fraudulent conduct associated with municipal securities transactions or public pension plans
  • Initial Coin Offerings and cryptocurrency fraud

Independent Knowledge and Independent Analysis

To be eligible for an award, whistleblowers must provide “original information” derived from either:

  • Independent knowledge – Firsthand, non-public information obtained through personal experiences, observations, or communications.
  • Independent analysis – Examining publicly-available data in a way that uncovers previously unknown violations.

In FY 2024, the SEC granted four awards based on independent analysis and 37 awards based on independent knowledge.

Protections for Whistleblowers

The SEC Whistleblower Program provides strong protections against employer retaliation.

Employers cannot fire, demote, suspend, or harass employees for reporting violations. Whistleblowers who experience retaliation may have legal recourse, including job reinstatement and compensation for damages.

How to Report Securities Fraud to the SEC

To report fraud under the SEC Whistleblower Program:

  1. Gather Evidence – Collect documents, emails, or records supporting your claim. The SEC values high-quality, original information.
  2. Submit a Tip – Use the SEC’s Tips, Complaints and Referrals Portal or Form TCR (Tip, Complaint, or Referral). A properly submitted Form TCR is required for a whistleblower award.
  3. Work with an Attorney – An experienced whistleblower attorney can guide you and protect your rights. Whistleblowers wishing to remain anonymous must be represented by an attorney.
  4. Stay Updated – The SEC may contact you for additional information or updates on your case. Continued cooperation may maximize award chances.

Determining Whistleblower Awards

The SEC determines award percentages based on several factors:

Factors That May Increase an Award:

  • Significance of Information – More valuable information leads to higher awards.
  • Assistance Provided – Helping SEC staff decipher transactions or provide key evidence can increase awards.
  • Law Enforcement Interest – Reports of ongoing violations harming investors may receive priority.
  • Internal Compliance Participation – While not required, internal reporting can increase award percentages.

Factors That May Decrease an Award:

  • Unreasonable Reporting Delay – Waiting too long to report a violation may reduce the award.
  • Culpability – Whistleblowers involved in misconduct may receive reduced payouts.
  • Interference with Internal Reporting Systems – Undermining internal compliance may lower an award.

Maximum Whistleblower Award Presumption

Under the 2020 Whistleblower Rule Amendments, whistleblowers are presumed eligible for the maximum 30% award if:

  • The total award does not exceed $5 million.
  • The claimant has no negative factors (e.g., culpability or delay).
  • The claim does not involve whistleblowers engaged in misconduct.

In FY 2024, the SEC applied this presumption in 90% of cases where the maximum award was $5 million or less.

Why Report Securities Violations?

By participating in the SEC Whistleblower Program, individuals help combat fraud, hold violators accountable, and protect investors. With over $2.2 billion awarded to 444 whistleblowers since 2011, the program plays a critical role in exposing wrongdoing.

If you have information about securities fraud, consider consulting a legal professional before submitting a tip.

Learn more about the SEC Whistleblower Program by visiting the SEC’s official Whistleblower FAQ page.

Do You Have Questions or Concerns About Whistleblower Reporting of Securities Fraud to the SEC?

Making the decision to come forward as a whistleblower and report securities fraud to the SEC can be challenging. At Kehoe Law Firm, P.C., our legal team understands the complexities involved and has extensive experience investigating fraud, prosecuting wrongdoing, and working with individuals who bravely expose securities violations.

If you have questions about voluntarily providing information to the SEC as a whistleblower—whether regarding eligibility for a whistleblower award, the reporting process, or the required submission format—please contact Kehoe Law Firm, P.C.

To speak directly with an attorney and receive a free, no-obligation legal consultation, please contact:

Michael Yarnoff, Esq.[email protected], [email protected] | (215) 792-6676, Ext. 804, or
John Kehoe, Esq.[email protected], [email protected] | (215) 792-6676, Ext. 801.

Your courage in whistleblower reporting of securities fraud helps protect investors and uphold market integrity. Kehoe Law Firm is here to guide you every step of the way.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors. We litigate securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

KLF’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses. 

    SEND US A MESSAGE

    Contact Us

    ADDRESS

    Kehoe Law Firm, P.C.
    2001 Market Street
    Suite 2500
    Philadelphia, PA 19103

    PHONE

    Tel: 215-792-6676

    EMAIL

    [email protected]

    Semtech Securities Class Action – SMTC

    Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Semtech Corporation (“Semtech” or the “Company”) (NASDAQ:SMTC) who purchased or acquired Semtech securities between August 27, 2024 and February 7, 2025 (the “Class Period”).

    Semtech Securities Class Action Allegations

    On February 20, 2025, a securities class action lawsuit was filed in federal court against Semtech and certain executives alleging violations of the federal securities laws.

    According to the complaint, the Semtech Defendants allegedly failed to disclose throughout the Class Period that the Company’s CopperEdge products did not meet the needs of server rack customers or end users, necessitating changes to rack architecture. As a result, CopperEdge sales would not ramp-up during fiscal 2026 and would be lower than anticipated. Consequently, the Defendants’ positive statements regarding the Company’s business, operations, and prospects were, allegedly, materially misleading and/or lacked a reasonable basis.

    Semtech Investors: Learn More About Your Legal Options

    Investors who purchased or acquired Semtech securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s Securities Questionnaire or send us a message to contact an attorney for a free, no-obligation legal evaluation.

    For direct inquiries, Semtech investors should contact Michael Yarnoff, Esq., at (215) 792-6676, Ext. 804, or [email protected], [email protected].

    LEAD PLAINTIFF DEADLINE

    Investors have until April 22, 2025 to petition the Court for appointment as lead plaintiff. The lead plaintiff typically has the largest financial interest and meets the adequacy and typicality requirements. Investors do not need to serve as lead plaintiff to share in any potential recovery.

    About Kehoe Law Firm, P.C.

    Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

    Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

    Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

    SEND US A MESSAGE

    Contact Us

    ADDRESS

    Kehoe Law Firm, P.C.
    2001 Market Street
    Suite 2500
    Philadelphia, PA 19103

    PHONE

    Tel: 215-792-6676

    EMAIL

    [email protected]

    Volkswagen Recalls 60,490 VW & Audi Vehicles Over Instrument Panel Display Issue

    Kehoe Law Firm, P.C. is notifying consumers that Volkswagen Group of America, Inc. (“Volkswagen”) has initiated a recall of 60,490 vehicles, including certain Volkswagen and Audi models, due to an instrument panel display issue that may increase the risk of rollaway and crashes.

    Affected Volkswagen & Audi Vehicles

    The recall impacts the following Volkswagen and Audi vehicles:

    • 2021-2023 Volkswagen ID.4
    • 2022-2023 Audi Q4 e-Tron
    • 2022-2023 Audi Q4 e-Tron Sportback

    Issue: Faulty Gear Position Display Increases Rollaway and Crash Risk

    According to Volkswagen, under certain circumstance, the “N” gear position may not be displayed on the instrument cluster when it should be. If the correct transmission gear position indicator is not shown and the electronic parking brake is not engaged, the driver may be unaware of the vehicle’s actual shift position, increasing the risk of vehicle rollaway and crashes.

    To mitigate risk, Volkswagen advises vehicle owners to confirm the red parking brake indicator light is illuminated before exiting their vehicle to ensure the parking brake is engaged.

    Recall Remedy: Free Software Update

    Dealers will provide an updated version of the brake control unit software for affected vehicles free of charge. No reimbursement program is planned, as the recalled vehicles are under warranty.

    Additional Recall Details

    More information about the recall can be found in the following official documents:

    How to Check if Your Vehicle Has Been Recalled

    To determine if your vehicle is subject to this recall, please click Check for Recalls to easily search vehicles, car seats, tires and other equipment for safety recalls, investigations, complaints and manufacturer communication.

    Questions About A Vehicle Defect or Recall?

    Vehicle owners and lessess affected by automotive defects or safety recalls are encouraged to contact Kehoe Law Firm, P.C. by sending us a message below or contacting Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation evaluation of potential legal claims.

    About Kehoe Law Firm, P.C. 

    Kehoe Law Firm, P.C is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors. We litigate securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

    Our class action legal services are on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

    Supreme Court Backs Whistleblower in E-Rate Fraud Case

    In an E-Rate fraud case brought under the False Claims Act (“FCA”) against Wisconsin Bell, the U.S. Supreme Court (“USSC”) recently ruled in favor of Todd Heath (“Heath”), in a significant decision which underscores the role of whistleblowers in exposing E-Rate fraud and enforcing accountability in federally managed funds.

    What is the E-Rate Program?

    The E-Rate (Education-Rate) program, established by the 1996 Telecommunications Act, helps schools and libraries afford internet and telecom services by drawing from the Universal Service Fund (“Fund”).

    Telecom carriers contribute to the Fund, which is administered by the Universal Service Administrative Company, a nonprofit designated by the Federal Communications Commission (“FCC”) to oversee collections and distributions in accordance with FCC regulations.

    A key regulation, the “lowest corresponding price” rule, ensures carriers do not charge schools and libraries more than comparable non-residential customers.

    Whistleblower Lawsuit Against Wisconsin Bell

    Heath, a telecommunications auditor, filed a lawsuit against Wisconsin Bell under the FCA, alleging that the company overcharged schools in violation of this rule and then submitted inflated reimbursement requests to the Fund, thereby defrauding the program.

    The FCA imposes civil liability on any person who “knowingly presents, or causes to be presented, a false or fraudulent claim” as statutorily defined. 31 U.S.C. §3729(a)(1)(A).

    Wisconsin Bell’s Defense & Lower Court Rulings

    Wisconsin Bell argued that these reimbursement requests did not qualify as FCA “claims” because the money originated from private carrier contributions rather than the government. However, courts, including the Seventh Circuit, rejected this argument, noting that the government played a direct role in regulating the Fund’s collection and distribution.

    Additionally, the government contributed more than $100 million directly from the U.S. Treasury, sourced from enforcement penalties and related actions.

    Because these government funds were deposited into and disbursed from the Fund, the courts determined that E-Rate reimbursements qualified as FCA “claims,” allowing Heath’s lawsuit to proceed.

    To read the USSC opinion, Wisconsin Bell, Inc. v. United States ex rel., click E-Rate fraud. 

    Impact on Whistleblowers & Fraud Enforcement

    The USSC’s decision reinforces the False Claims Act’s role in protecting federal programs and highlights the critical role of whistleblowers in identifying and exposing fraud against the government

    Whistleblowers: Know Your Rights 

    Kehoe Law Firm is dedicated to protecting whistleblower rights, guiding them through the legal process, and pursuing potential financial rewards for reporting fraud.

    For a free, no-obligation evaluation of whistleblower claims, send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected]

    KLF’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses. 

    About Kehoe Law Firm, P.C.

    Kehoe Law Firm, P.C. is a plaintiff-side class action firm, fiercely committed to safeguarding investors and consumers from corporate fraud and misconduct. Nationally recognized, our attorneys have taken the reins as Lead or Co-Lead Counsel in high-profile cases, securing over $10 billion in recoveries for institutional and individual investors and consumers. Through relentless class action litigation, we tackle securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations head-on. Beyond that, we champion whistleblowers and fight against data breaches, consumer scams, employment law abuses, retirement plan mismanagement, and deceptive business practices. With a no-nonsense, results-focused approach, we chase down meaningful outcomes—delivering justice and substantial recoveries for those we represent.

      SEND US A MESSAGE

      Contact Us

      ADDRESS

      Kehoe Law Firm, P.C.
      2001 Market Street
      Suite 2500
      Philadelphia, PA 19103

      PHONE

      Tel: 215-792-6676

      EMAIL

      [email protected]

      Maravai LifeSciences Holdings, Inc. – MRVI

      Kehoe Law Firm, P.C. (“KLF”) is investigating potential securities claims on behalf of investors of Maravai LifeSciences Holdings, Inc. (“Maravai LifeSciences,” “Maravai,” or the “Company”) (NASDAQ:MRVI).

      Maravai LifeSciences investors who acquired their securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”) and suffered financial losses are encouraged to complete KLF’s Stockholder Information Request Form or send us a message to reach an attorney for a free, no-obligation legal evaluation of potential claims.

      Delayed Earnings Release and Notification of Late Filing of Its Annual Report 

      On February 25, 2025, Maravai LifeSciences announced that it is postponing its previously announced earnings release and call scheduled for February 25, 2025, as well as that it intends to file a Form 12b-25, Notification of Late Filing, with the SEC and will delay the filing its annual report on Form 10-K for the fiscal year ended December 31, 2024.

      Maravai LifeSciences also reported that it “. . . requires additional time to complete its year-end financial close process for reasons related primarily to the following items. First, Maravai requires additional time to complete its assessment of a potential non-cash impairment charge related to goodwill associated with its previous acquisition of Alphazyme LLC.”

      Next, Maravai stated that it “. . . requires additional time to assess an error identified during the close process with respect to revenue recognition associated with a single shipment identified in year-end audit procedures that resulted in approximately $3.9 million in revenue being recorded in the final week of the second quarter of 2024 upon shipment when it should have been recorded in the first week of the third quarter of 2024 upon receipt by the customer.”

      The price of Maravai stock dropped more than 20% by the close of trading on February 25, 2025.

      Maravai Reports Certain Financial Statements Should No Longer Be Relied Upon 

      On March 18, 2025, Maravai reported that “[o]n March 17, 2025, the Audit Committee of the Board of Directors of the Company . . . concluded that the Company’s interim financial statements and related disclosures included in the Company’s Quarterly Reports on Form 10-Q for the fiscal quarters ended June 30, 2024 . . ., and September 30, 2024 . . ., and as of and for the interim periods ended June 30, 2024, and September 30, 2024 . . ., included in its Quarterly Reports for Q2 2024 and Q3 2024, should no longer be relied upon and are being restated . . . as set forth in the Company’s consolidated financial statements included with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 . . ..”

      Restatement to Correct an Error Associated with a Single Shipment

      The restatement, according to Maravai, “. . . primarily corrects an error identified during the year-end financial close process with respect to revenue recognition associated with a single shipment that resulted in approximately $3.9 million in revenue being recorded in the final week of the second quarter of 2024 upon shipment when it should have been recorded in the first week of the third quarter of 2024 upon receipt by the customer.”

      Additionally, Maravai LifeSciences reported that “[i]n connection with these matters, the Company concluded that, as of December 31, 2024, the Company’s disclosure controls and procedures were not effective at a reasonable assurance level and its internal control over financial reporting was ineffective, due to the material weaknesses in internal control over financial reporting described in Part II, Item 9A of the 2024 Form 10-K being filed concurrently with [the] Form 8-K.” 

      Maravai LifeSciences Securities Fraud Class Action Lawsuit 

      On March 3, 2025, a class action complaint alleging violations of the federal securities laws was filed against Maravai LifeSciences on behalf of investors who acquired Maravai LifeSciences securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).

      According to the class action complaint, throughout the Class Period, the Maravai LifeSciences Defendants allegedly made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

      Allegedly, the Maravai LifeSciences Defendants failed to disclose to investors that Maravai lacked adequate internal controls over financial reporting related to revenue recognition, and as a result, the Company inaccurately recognized revenue on certain transactions during fiscal 2024; its goodwill was overstated; and, consequently, the Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

      Maravai LifeSciences Investors: Learn More About the Securities Investigation and Your Legal Options

      Maravai LifeSciences investors who acquired their securities during the Class Period and suffered financial losses may obtain more information about the class action lawsuit and securities investigation by contacting John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected].

      About Kehoe Law Firm, P.C.

      Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

      Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

      Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

       

      SEND US A MESSAGE

      Contact Us

      ADDRESS

      Kehoe Law Firm, P.C.
      2001 Market Street
      Suite 2500
      Philadelphia, PA 19103

      PHONE

      Tel: 215-792-6676

      EMAIL

      [email protected]